Advertisement

Persistent Peripheral Inflammation Attenuates Morphine-Induced Periaqueductal Gray Glial Cell Activation and Analgesic Tolerance in the Male Rat

Published:February 07, 2013DOI:https://doi.org/10.1016/j.jpain.2012.12.010

      Abstract

      Morphine is among the most prevalent analgesics prescribed for chronic pain. However, prolonged morphine treatment results in the development of analgesic tolerance. An abundance of evidence has accumulated indicating that central nervous system glial cell activity facilitates pain transmission and opposes morphine analgesia. While the midbrain ventrolateral periaqueductal gray (vlPAG) is an important neural substrate mediating pain modulation and the development of morphine tolerance, no studies have directly assessed the role of PAG glia. Here we test the hypothesis that morphine-induced increases in vlPAG glial cell activity contribute to the development of morphine tolerance. As morphine is primarily consumed for the alleviation of severe pain, the influence of persistent inflammatory pain was also assessed. Administration of morphine, in the absence of persistent inflammatory pain, resulted in the rapid development of morphine tolerance and was accompanied by a significant increase in vlPAG glial activation. In contrast, persistent inflammatory hyperalgesia, induced by intraplantar administration of complete Freund’s adjuvant (CFA), significantly attenuated the development of morphine tolerance. No significant differences were noted in vlPAG glial cell activation for CFA-treated animals versus controls. These results indicate that vlPAG glia are modulated by a persistent pain state, and implicate vlPAG glial cells as possible regulators of morphine tolerance.

      Perspective

      The development of morphine tolerance represents a significant impediment to its use in the management of chronic pain. We report that morphine tolerance is accompanied by increased glial cell activation within the vlPAG, and that the presence of a persistent pain state prevented vlPAG glial activation and attenuated morphine tolerance.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adam F.
        • Bonnet F.
        • Le Bars D.
        Tolerance to morphine analgesia: Evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific nmda antagonist.
        Neuropharmacology. 2006; 51: 191-202
        • Adam F.
        • Dufour E.
        • Le Bars D.
        The glycine site-specific NMDA antagonist (+)-ha966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.
        Neuropharmacology. 2008; 54: 588-596
        • Allen R.M.
        • Dykstra L.A.
        Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist.
        Psychopharmacology (Berl). 2000; 148: 59-65
        • Basbaum A.I.
        • Fields H.L.
        Endogenous pain control mechanisms: Review and hypothesis.
        Ann Neurol. 1978; 4: 451-462
        • Basbaum A.I.
        • Fields H.L.
        Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry.
        Annu Rev Neurosci. 1984; 7: 309-338
        • Behbehani M.M.
        • Fields H.L.
        Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia.
        Brain Res. 1979; 170: 85-93
        • Beitz A.J.
        The midbrain periaqueductal gray in the rat. I. Nuclear volume, cell number, density, orientation, and regional subdivisions.
        J Comp Neurol. 1985; 237: 445-459
        • Bernabei R.
        • Gambassi G.
        The sage database: Introducing functional outcomes in geriatric pharmaco-epidemiology.
        J Am Geriatr Soc. 1998; 46: 251-252
        • Bogulavsky J.J.
        • Gregus A.M.
        • Kim P.T.
        • Costa A.C.
        • Rajadhyaksha A.M.
        • Inturrisi C.E.
        Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance.
        J Pharmacol Exp Ther. 2009; 328: 579-587
        • Burgos E.
        • Gomez-Nicola D.
        • Pascual D.
        • Martin M.I.
        • Nieto-Sampedro M.
        • Goicoechea C.
        Cannabinoid agonist win 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
        Eur J Pharmacol. 2012; 682: 62-72
        • Cao L.
        • Tanga F.Y.
        • Deleo J.A.
        The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain.
        Neuroscience. 2009; 158: 896-903
        • Carpenter S.
        • Carlson T.
        • Dellacasagrande J.
        • Garcia A.
        • Gibbons S.
        • Hertzog P.
        • Lyons A.
        • Lin L.L.
        • Lynch M.
        • Monie T.
        • Murphy C.
        • Seidl K.J.
        • Wells C.
        • Dunne A.
        • O’Neill L.A.
        Tril, a functional component of the TLR4 signaling complex, highly expressed in brain.
        J Immunol. 2009; 183: 3989-3995
        • Chen F.L.
        • Dong Y.L.
        • Zhang Z.J.
        • Cao D.L.
        • Xu J.
        • Hui J.
        • Zhu L.
        • Gao Y.J.
        Activation of astrocytes in the anterior cingulate cortex contributes to the affective component of pain in an inflammatory pain model.
        Brain Res Bull. 2012; 87: 60-66
        • Chieng B.
        • Christie M.J.
        Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro.
        Br J Pharmacol. 1994; 113: 303-309
        • Cichewicz D.L.
        • Welch S.P.
        Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol.
        J Pharmacol Exp Ther. 2003; 305: 812-817
        • Colburn R.W.
        • Rickman A.J.
        • DeLeo J.A.
        The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior.
        Exp Neurol. 1999; 157: 289-304
        • Collett B.J.
        Opioid tolerance: The clinical perspective.
        Br J Anaesth. 1998; 81: 58-68
        • Commons K.G.
        • Aicher S.A.
        • Kow L.M.
        • Pfaff D.W.
        Presynaptic and postsynaptic relations of mu-opioid receptors to gamma-aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons.
        J Comp Neurol. 2000; 419: 532-542
        • Cowan D.T.
        • Allan L.G.
        • Libretto S.E.
        • Griffiths P.
        Opioid drugs: A comparative survey of therapeutic and “street” use.
        Pain Med. 2001; 2: 193-203
        • Cui Y.
        • Chen Y.
        • Zhi J.L.
        • Guo R.X.
        • Feng J.Q.
        • Chen P.X.
        Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance.
        Brain Res. 2006; 1069: 235-243
        • DeLeo J.A.
        • Tanga F.Y.
        • Tawfik V.L.
        Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia.
        Neuroscientist. 2004; 10: 40-52
        • Downer E.J.
        Cannabinoids and innate immunity: Taking a toll on neuroinflammation.
        ScientificWorldJournal. 2011; 11: 855-865
        • Dworkin R.H.
        • Turk D.C.
        • Farrar J.T.
        • Haythornthwaite J.A.
        • Jensen M.P.
        • Katz N.P.
        • Kerns R.D.
        • Stucki G.
        • Allen R.R.
        • Bellamy N.
        • Carr D.B.
        • Chandler J.
        • Cowan P.
        • Dionne R.
        • Galer B.S.
        • Hertz S.
        • Jadad A.R.
        • Kramer L.D.
        • Manning D.C.
        • Martin S.
        • McCormick C.G.
        • McDermott M.P.
        • McGrath P.
        • Quessy S.
        • Rappaport B.A.
        • Robbins W.
        • Robinson J.P.
        • Rothman M.
        • Royal M.A.
        • Simon L.
        • Stauffer J.W.
        • Stein W.
        • Tollett J.
        • Wernicke J.
        • Witter J.
        Core outcome measures for chronic pain clinical trials: Immpact recommendations.
        Pain. 2005; 113: 9-19
        • Fields H.L.
        • Basbaum A.I.
        Brainstem control of spinal pain-transmission neurons.
        Annu Rev Physiol. 1978; 40: 217-248
        • Fields H.L.
        • Heinricher M.M.
        Anatomy and physiology of a nociceptive modulatory system.
        Philos Trans R Soc Lond B Biol Sci. 1985; 308: 361-374
        • Galer B.S.
        • Lee D.
        • Ma T.
        • Nagle B.
        • Schlagheck T.G.
        Morphidex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance.
        Pain. 2005; 115: 284-295
        • Gazda L.S.
        • Milligan E.D.
        • Hansen M.K.
        • Twining C.M.
        • Poulos N.M.
        • Chacur M.
        • O’Connor K.A.
        • Armstrong C.
        • Maier S.F.
        • Watkins L.R.
        • Myers R.R.
        Sciatic inflammatory neuritis (sin): Behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production.
        J Peripher Nerv Syst. 2001; 6: 111-129
        • Greenspan J.D.
        • Craft R.M.
        • LeResche L.
        • Arendt-Nielsen L.
        • Berkley K.J.
        • Fillingim R.B.
        • Gold M.S.
        • Holdcroft A.
        • Lautenbacher S.
        • Mayer E.A.
        • Mogil J.S.
        • Murphy A.Z.
        • Traub R.J.
        Studying sex and gender differences in pain and analgesia: A consensus report.
        Pain. 2007; 132: S26-S45
        • Hargreaves K.
        • Dubner R.
        • Brown F.
        • Flores C.
        • Joris J.
        A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.
        Pain. 1988; 32: 77-88
        • Honore P.
        • Rogers S.D.
        • Schwei M.J.
        • Salak-Johnson J.L.
        • Luger N.M.
        • Sabino M.C.
        • Clohisy D.R.
        • Mantyh P.W.
        Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.
        Neuroscience. 2000; 98: 585-598
        • Horvath R.J.
        • DeLeo J.A.
        Morphine enhances microglial migration through modulation of P2X4 receptor signaling.
        J Neurosci. 2009; 29: 998-1005
        • Hutchinson M.R.
        • Coats B.D.
        • Lewis S.S.
        • Zhang Y.
        • Sprunger D.B.
        • Rezvani N.
        • Baker E.M.
        • Jekich B.M.
        • Wieseler J.L.
        • Somogyi A.A.
        • Martin D.
        • Poole S.
        • Judd C.M.
        • Maier S.F.
        • Watkins L.R.
        Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.
        Brain Behav Immun. 2008; 22: 1178-1189
        • Hutchinson M.R.
        • Lewis S.S.
        • Coats B.D.
        • Skyba D.A.
        • Crysdale N.Y.
        • Berkelhammer D.L.
        • Brzeski A.
        • Northcutt A.
        • Vietz C.M.
        • Judd C.M.
        • Maier S.F.
        • Watkins L.R.
        • Johnson K.W.
        Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
        Brain Behav Immun. 2009; 23: 240-250
        • Hutchinson M.R.
        • Zhang Y.
        • Shridhar M.
        • Evans J.H.
        • Buchanan M.M.
        • Zhao T.X.
        • Slivka P.F.
        • Coats B.D.
        • Rezvani N.
        • Wieseler J.
        • Hughes T.S.
        • Landgraf K.E.
        • Chan S.
        • Fong S.
        • Phipps S.
        • Falke J.J.
        • Leinwand L.A.
        • Maier S.F.
        • Yin H.
        • Rice K.C.
        • Watkins L.R.
        Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
        Brain Behav Immun. 2010; 24: 83-95
        • Iwai S.
        • Kiguchi N.
        • Kobayashi Y.
        • Fukazawa Y.
        • Saika F.
        • Ueno K.
        • Yamamoto C.
        • Kishioka S.
        Inhibition of morphine tolerance is mediated by painful stimuli via central mechanisms.
        Drug Discov Ther. 2012; 6: 31-37
        • Juni A.
        • Klein G.
        • Pintar J.E.
        • Kest B.
        Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
        Neuroscience. 2007; 147: 439-444
        • Kalso E.
        • Edwards J.E.
        • Moore R.A.
        • McQuay H.J.
        Opioids in chronic non-cancer pain: Systematic review of efficacy and safety.
        Pain. 2004; 112: 372-380
        • Kalyuzhny A.E.
        • Wessendorf M.W.
        Relationship of mu- and delta-opioid receptors to gabaergic neurons in the central nervous system, including antinociceptive brainstem circuits.
        J Comp Neurol. 1998; 392: 528-547
        • Kleibeuker W.
        • Ledeboer A.
        • Eijkelkamp N.
        • Watkins L.R.
        • Maier S.F.
        • Zijlstra J.
        • Heijnen C.J.
        • Kavelaars A.
        A role for g protein-coupled receptor kinase 2 in mechanical allodynia.
        Eur J Neurosci. 2007; 25: 1696-1704
        • Laflamme N.
        • Rivest S.
        Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components.
        Faseb J. 2001; 15: 155-163
        • Lane D.A.
        • Tortorici V.
        • Morgan M.M.
        Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray.
        Neuroscience. 2004; 125: 63-69
        • Lane D.A.
        • Patel P.A.
        • Morgan M.M.
        Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
        Neuroscience. 2005; 135: 227-234
        • Laprairie J.L.
        • Murphy A.Z.
        Neonatal injury alters adult pain sensitivity by increasing opioid tone in the periaqueductal gray.
        Front Behav Neurosci. 2009; 3: 31
        • Lewis M.E.
        • Khachaturian H.
        • Schafer M.K.
        • Watson S.J.
        Anatomical approaches to the study of neuropeptides and related mrna in the central nervous system.
        Res Publ Assoc Res Nerv Ment Dis. 1986; 64: 79-109
        • Lin T.
        • Li K.
        • Zhang F.Y.
        • Zhang Z.K.
        • Light A.R.
        • Fu K.Y.
        Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models.
        J Neuroimmunol. 2007; 192: 40-48
        • Loyd D.R.
        • Murphy A.Z.
        Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: A potential circuit mediating the sexually dimorphic actions of morphine.
        J Comp Neurol. 2006; 496: 723-738
        • Loyd D.R.
        • Morgan M.M.
        • Murphy A.Z.
        Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: A potential mechanism for sex differences in antinociception.
        Neuroscience. 2007; 147: 456-468
        • Loyd D.R.
        • Morgan M.M.
        • Murphy A.Z.
        Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat.
        Eur J Neurosci. 2008; 27: 1517-1524
        • Loyd D.R.
        • Wang X.
        • Murphy A.Z.
        Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia.
        J Neurosci. 2008; 28: 14007-14017
        • Mi W.L.
        • Mao-Ying Q.L.
        • Wang X.W.
        • Li X.
        • Yang C.J.
        • Jiang J.W.
        • Yu J.
        • Wang J.
        • Liu Q.
        • Wang Y.Q.
        • Wu G.C.
        Involvement of spinal neurotrophin-3 in electroacupuncture analgesia and inhibition of spinal glial activation in rat model of monoarthritis.
        J Pain. 2011; 12: 974-984
        • Mika J.
        Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.
        Pharmacol Rep. 2008; 60: 297-307
        • Mika J.
        • Wawrzczak-Bargiela A.
        • Osikowicz M.
        • Makuch W.
        • Przewlocka B.
        Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
        Brain Behav Immun. 2009; 23: 75-84
        • Morgan M.M.
        • Fossum E.N.
        • Stalding B.M.
        • King M.M.
        Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat.
        J Pain. 2006; 7: 358-366
        • Morgan M.M.
        • Christie M.J.
        Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human.
        Br J Pharmacol. 2011; 164: 1322-1334
        • Morioka N.
        • Inoue A.
        • Hanada T.
        • Kumagai K.
        • Takeda K.
        • Ikoma K.
        • Hide I.
        • Tamura Y.
        • Shiomi H.
        • Dohi T.
        • Nakata Y.
        Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance p release from primary afferent neurons: Involvement of cgmp-independent mechanisms.
        Neuropharmacology. 2002; 43: 868-876
        • Murphy A.Z.
        • Hoffman G.E.
        Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem pathway: A potential circuit for the initiation of male sexual behavior.
        J Comp Neurol. 2001; 438: 191-212
        • Ogoshi F.
        • Yin H.Z.
        • Kuppumbatti Y.
        • Song B.
        • Amindari S.
        • Weiss J.H.
        Tumor necrosis-factor-alpha (tnf-alpha) induces rapid insertion of CA2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-a/k) channels in a subset of hippocampal pyramidal neurons.
        Exp Neurol. 2005; 193: 384-393
        • Paxinos G.
        • Watson C.
        The rat brain in stereotaxic coordinates.
        Academic Press, New York, NY1977
        • Popik P.
        • Kozela E.
        • Pilc A.
        Selective agonist of group ii glutamate metabotropic receptors, ly354740, inhibits tolerance to analgesic effects of morphine in mice.
        Br J Pharmacol. 2000; 130: 1425-1431
        • Raghavendra V.
        • Rutkowski M.D.
        • DeLeo J.A.
        The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.
        J Neurosci. 2002; 22: 9980-9989
        • Raghavendra V.
        • Tanga F.
        • Rutkowski M.D.
        • DeLeo J.A.
        Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: Mechanistic implications of spinal glia and proinflammatory cytokines.
        Pain. 2003; 104: 655-664
        • Raghavendra V.
        • Tanga F.Y.
        • DeLeo J.A.
        Complete freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the cns.
        Eur J Neurosci. 2004; 20: 467-473
        • Raghavendra V.
        • Tanga F.Y.
        • DeLeo J.A.
        Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats.
        Neuropsychopharmacology. 2004; 29: 327-334
        • Rauck R.L.
        What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
        Pain Pract. 2009; 9: 468-479
        • Romero A.
        • Hernandez L.
        • Garcia-Nogales P.
        • Puig M.M.
        Deletion of the inducible nitric oxide synthase gene reduces peripheral morphine tolerance in a mouse model of chronic inflammation.
        Fundam Clin Pharmacol. 2010; 24: 317-323
        • Siddall P.J.
        • Cousins M.J.
        Persistent pain as a disease entity: Implications for clinical management.
        Anesth Analg. 2004; 99 (table of contents): 510-520
        • Sim-Selley L.J.
        • Scoggins K.L.
        • Cassidy M.P.
        • Smith L.A.
        • Dewey W.L.
        • Smith F.L.
        • Selley D.E.
        Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.
        Br J Pharmacol. 2007; 151: 1324-1333
        • Smith F.L.
        • Javed R.
        • Elzey M.J.
        • Welch S.P.
        • Selley D.
        • Sim-Selley L.
        • Dewey W.L.
        Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors.
        Brain Res. 2002; 958: 28-35
        • Smith P.A.
        • Selley D.E.
        • Sim-Selley L.J.
        • Welch S.P.
        Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
        Eur J Pharmacol. 2007; 571: 129-137
        • Song P.
        • Zhao Z.Q.
        The involvement of glial cells in the development of morphine tolerance.
        Neurosci Res. 2001; 39: 281-286
        • Stellwagen D.
        • Beattie E.C.
        • Seo J.Y.
        • Malenka R.C.
        Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha.
        J Neurosci. 2005; 25: 3219-3228
        • Sun S.
        • Cao H.
        • Han M.
        • Li T.T.
        • Pan H.L.
        • Zhao Z.Q.
        • Zhang Y.Q.
        New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.
        Pain. 2007; 129: 64-75
        • Sweitzer S.M.
        • Schubert P.
        • DeLeo J.A.
        Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.
        J Pharmacol Exp Ther. 2001; 297: 1210-1217
        • Tanga F.Y.
        • Raghavendra V.
        • Nutile-McMenemy N.
        • Marks A.
        • Deleo J.A.
        Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain.
        Neuroscience. 2006; 140: 1003-1010
        • Tortorici V.
        • Robbins C.S.
        • Morgan M.M.
        Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat.
        Behav Neurosci. 1999; 113: 833-839
        • Trescot A.M.
        • Boswell M.V.
        • Atluri S.L.
        • Hansen H.C.
        • Deer T.R.
        • Abdi S.
        • Jasper J.F.
        • Singh V.
        • Jordan A.E.
        • Johnson B.W.
        • Cicala R.S.
        • Dunbar E.E.
        • Helm 2nd, S.
        • Varley K.G.
        • Suchdev P.K.
        • Swicegood J.R.
        • Calodney A.K.
        • Ogoke B.A.
        • Minore W.S.
        • Manchikanti L.
        Opioid guidelines in the management of chronic non-cancer pain.
        Pain Physician. 2006; 9: 1-39
        • Trescot A.M.
        • Glaser S.E.
        • Hansen H.
        • Benyamin R.
        • Patel S.
        • Manchikanti L.
        Effectiveness of opioids in the treatment of chronic non-cancer pain.
        Pain Physician. 2008; 11: S181-S200
        • Uhelski M.L.
        • Boyette-Davis J.A.
        • Fuchs P.N.
        Chronic inflammatory pain does not attenuate the development of tolerance to chronic morphine in adult male rats.
        Pharmacol Biochem Behav. 2011; 98: 325-330
        • Viviani B.
        • Bartesaghi S.
        • Gardoni F.
        • Vezzani A.
        • Behrens M.M.
        • Bartfai T.
        • Binaglia M.
        • Corsini E.
        • Di Luca M.
        • Galli C.L.
        • Marinovich M.
        Interleukin-1beta enhances nmda receptor-mediated intracellular calcium increase through activation of the SRC family of kinases.
        J Neurosci. 2003; 23: 8692-8700
        • Walker J.M.
        • Huang S.M.
        • Strangman N.M.
        • Tsou K.
        • Sanudo-Pena M.C.
        Pain modulation by release of the endogenous cannabinoid anandamide.
        Proc Natl Acad Sci U S A. 1999; 96: 12198-12203
        • Wang X.
        • Traub R.J.
        • Murphy A.Z.
        Persistent pain model reveals sex difference in morphine potency.
        Am J Physiol Regul Integr Comp Physiol. 2006; 291: R300-R306
        • Watkins L.R.
        • Milligan E.D.
        • Maier S.F.
        Glial activation: A driving force for pathological pain.
        Trends Neurosci. 2001; 24: 450-455
        • Watkins L.R.
        • Milligan E.D.
        • Maier S.F.
        Spinal cord glia: New players in pain.
        Pain. 2001; 93: 201-205
        • Watkins L.R.
        • Hutchinson M.R.
        • Johnston I.N.
        • Maier S.F.
        Glia: Novel counter-regulators of opioid analgesia.
        Trends Neurosci. 2005; 28: 661-669
        • Watkins L.R.
        • Hutchinson M.R.
        • Ledeboer A.
        • Wieseler-Frank J.
        • Milligan E.D.
        • Maier S.F.
        Norman cousins lecture. Glia as the “bad guysrdquo;: Implications for improving clinical pain control and the clinical utility of opioids.
        Brain Behav Immun. 2007; 21: 131-146
        • Watkins L.R.
        • Hutchinson M.R.
        • Rice K.C.
        • Maier S.F.
        The “toll” of opioid-induced glial activation: Improving the clinical efficacy of opioids by targeting glia.
        Trends Pharmacol Sci. 2009; 30: 581-591
        • Wilson A.R.
        • Maher L.
        • Morgan M.M.
        Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
        Neuropharmacology. 2008; 55: 1219-1225
        • Wilson-Poe A.R.
        • Morgan M.M.
        • Aicher S.A.
        • Hegarty D.M.
        Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.
        Neuroscience. 2012; 213: 191-200